CPT code 93892 denotes a transcranial Doppler ultrasound study performed without microbubble contrast to evaluate intracranial arterial blood flow and detect embolic signals. This diagnostic vascular ultrasound is used in neurologic and vascular evaluations where noninvasive assessment of cerebral hemodynamics and emboli surveillance is needed. Nationally, the code matters for stroke workups, cerebrovascular disease monitoring, and peri-procedural emboli surveillance because it supports clinical decision-making without invasive angiography.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The content outlines payer coverage patterns, typical sites of service, and clinical contexts where TCD without contrast is applied. Readers will find a concise clinical description, the expected service type and typical settings, and reference points for billing and documentation considerations.

The publication provides benchmarks and policy-relevant context for CPT code 93892, including utilization drivers, common clinical indications, and where practice patterns intersect with payer policy. Data not available in the input for specific reimbursement rates, ICD-10 pairings, or associated taxonomies is noted as unavailable; the focus remains on the code’s clinical role and the payer landscape affecting national adoption and coverage.